A mathematical model for pattern of change in beta-cell reserve and factors affecting residual reserve within the first 2 years of type 1 diabetes
- PMID: 12553560
- DOI: 10.1007/BF03344073
A mathematical model for pattern of change in beta-cell reserve and factors affecting residual reserve within the first 2 years of type 1 diabetes
Abstract
The aim of this study was to investigate the effects of age, duration of diabetes, sex and ICA (Islet cell cytoplasmic antibody) on beta-cell reserves and to develop a model within the first 2 years of Type 1 diabetes. Beta-cell reserve is evaluated as fasting (FCp) and 1 mg i.v. glucagon stimulated C-peptide (SCp) levels in 58 Type 1 diabetics and in 12 normoglycemic subjects. Patients were divided into 3 groups according to duration of diabetes: Group I (2.5+/-0.3 weeks), Group II (13.4+/-1.2 months) and Group III (24.2+/-1.8 months). FCp/SCp level in nmol/l (mean+/-SE) were as follows. Group I: 0.21+/-0.02/0.38+/-0.04, Group II: 0.15+/-0.01/0.27+/-0.02, Group III: 0.07+/-0.01/0.11+/-0.02, CONTROL GROUP: 0.42+/-0.09/1.29+/-0.13. The scatter plots of C-peptide levels vs time in all the diabetic patients fitted in to a 4th-order polynomial regression (R: 0.96-0.98). Age was strongly correlated with FCp (rs: 0.46, p<0.05) and ICA positivity affected Cp-levels negatively (p>0.05). In conclusion, as the duration of diabetes increases, response time to glucagon prolongs and amplitude of it shortens. Duration of diabetes of less than 2 weeks, feminity, puberty and ICA positivity affect beta-cell reserve negatively, conversely, masculinity, post-puberty, older age and ICA negativity affect the reserve positively. The dynamics of C-peptide response to glucagon follow a mathematical model and Type 1 diabetes causes a decrease not only in the amplitude of the response but also in the duration of the response.
Similar articles
-
Beta-cell function in relation to islet cell antibodies during the first 3 yr after clinical diagnosis of diabetes in type II diabetic patients.Diabetes Care. 1993 Jun;16(6):902-10. doi: 10.2337/diacare.16.6.902. Diabetes Care. 1993. PMID: 8325204
-
Correlation between residual beta-cell function and islet cell antibodies in newly diagnosed type I diabetes. Follow-up study.Diabetes. 1989 Nov;38(11):1396-401. doi: 10.2337/diab.38.11.1396. Diabetes. 1989. PMID: 2695374
-
Relationships among islet cell antibodies, residual beta-cell function, and metabolic control in patients with insulin-dependent diabetes mellitus of long duration: use of a sensitive C-peptide radioimmunoassay.Metabolism. 1990 Sep;39(9):925-30. doi: 10.1016/0026-0495(90)90302-s. Metabolism. 1990. PMID: 2202883
-
Correlations between fasting plasma C-peptide, glucagon-stimulated plasma C-peptide, and urinary C-peptide in insulin-treated diabetics.Diabetes Care. 1987 Jul-Aug;10(4):487-90. doi: 10.2337/diacare.10.4.487. Diabetes Care. 1987. PMID: 3304899
-
C-Peptide reserve in insulin-dependent diabetes. Comparative responses to glucose, glucagon and tolbutamide.Diabetologia. 1980 Sep;19(3):183-8. doi: 10.1007/BF00275266. Diabetologia. 1980. PMID: 6997119
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous